3
项与 Influenza vaccine(GSK) 相关的临床试验Exploratory Study Into Age-related Immunological Differences Related to Immunogenicity in Influenza Vaccination and Herpes Zoster Vaccination
Vaccines are used to prevent infectious diseases worldwide. Unfortunately, many vaccines, like the flu vaccine, are less effective in older adults.
This single-centre open label partially randomised, partially placebo-controlled trial evaluates the differences in immune response between young and older adults after vaccination with a quadrivalent inactivated influenza vaccine and an adjuvanted herpes zoster vaccination.
Exploring the underlying mechanisms between the differences in immunogenicity can provide important information for future vaccine development.
Maternal Determinants of Immunity to Influenza (MADI-01)
The overall objective of the project is to determine the impact of pregnancy on the response to influenza immunization.
Effectiveness of Influenza Vaccination (Alfarix)in Preventing Clinical Influenza Cases Among General Practitioners: Non-Randomized Clinical Trial.
Besides the personal protection, influenza vaccination especially needs to prevent transmission of influenza between GPs and their patients. The question remains if the vaccine is adding substantial benefit to the natural acquired immunity of GPs. Doubts are raised if an inactivated vaccine, which elicit especially humoral immune response, can give enough protection against virus replication and subclinical influenza infections. Until now no effectiveness studies of influenza vaccination were performed among GPs. This study will assess the effectiveness of an inactivated influenza vaccine in GPs against clinical respiratory tract infections and more particular against influenza cases with influenza positive nose and throat swabs (diagnosed by RT-PCR).
100 项与 Influenza vaccine(GSK) 相关的临床结果
100 项与 Influenza vaccine(GSK) 相关的转化医学
100 项与 Influenza vaccine(GSK) 相关的专利(医药)
100 项与 Influenza vaccine(GSK) 相关的药物交易